Duda D, Lorenz W, Celik I
Department of Anaesthesiology, St Hildegardis-Academic Hospital of the Johannes Gutenberg-University, DE-55131 Mainz, Germany.
Inflamm Res. 2002 Oct;51(10):495-9. doi: 10.1007/pl00012418.
Mesenteric traction syndrome is described as sudden tachycardia, hypotension and flush. Among other etiological factors eventeration or mesenteric traction of the small intestine may cause histamine release from mesenteric mast cells. We hypothesized that mesenteric traction syndrome may be positively influenced by prophylactic antihistamine administration.
Male patients (n = 17, ASA groups III-IV, 48-78 years old) were investigated in a randomised double blind study during elective abdominal aortic aneurysm (AAA) repair. Eight patients had pre-anaesthetic prophylaxis with dimetindene (H1-receptor antagonist) plus cimetidine (H2-receptor antagonist), 9 patients received placebo. Anaesthesia and invasive haemodynamic monitoring were standardised in all patients. Haemodynamic parameters, plasma histamine concentrations and clinical symptoms were determined 1 min after skin incision, as well as 5 and 20 min after mesenteric traction. Statistical analyses were performed using the Student's t-test, Chi2-test for incidences and Mann-Whitney-U-test for continuous data.
The incidence of histamine release was 55.5% (5/9) in the placebo group vs. 37.5% (3/8) in the antihistamine group (p > 0.05, Chi2-test). Plasma histamine levels (mean +/- SD) were higher in the placebo group than in the antihistamine group at 5 and 20 min after mesenteric traction but the difference did not reach statistical significance. Arrhythmias were significantly more frequent in the placebo group (6 times) than in the antihistamine group (none) (p = 0.005 Chi2-test). Systolic blood pressure was not statistically different between groups (e.g. 5 min after mesenteric traction, mean +/- SD; placebo 111 +/- 20 mm Hg vs. antihistamines 119 +/- 35 mm Hg). However, in the placebo group the haemodynamics only stabilised 5 min after mesenteric traction when anaesthetic gas concentration was repeatedly reduced and vasopressor/volume administration was increased (placebo-group = 20 times/antihistamine-group = 8 times, p = 0.001, t-test).
Prophylactic administration of antihistamines reduced the incidence of histamine release as well as the incidence of arrhythmias and the amount of stabilising measures during mesenteric traction. Prophylaxis with H1 and H2 antihistamines may be of perioperative benefit and should therefore be considered in AAA-surgery.
肠系膜牵拉综合征表现为突发心动过速、低血压和面色潮红。在其他病因中,小肠疝出或肠系膜牵拉可能导致肠系膜肥大细胞释放组胺。我们假设预防性给予抗组胺药可能对肠系膜牵拉综合征产生积极影响。
在择期腹主动脉瘤(AAA)修复手术期间,对男性患者(n = 17,ASA III-IV级,48 - 78岁)进行了一项随机双盲研究。8例患者在麻醉前接受了二甲茚定(H1受体拮抗剂)加西咪替丁(H2受体拮抗剂)的预防性用药,9例患者接受安慰剂。所有患者的麻醉和有创血流动力学监测均标准化。在皮肤切开后1分钟以及肠系膜牵拉后5分钟和20分钟测定血流动力学参数、血浆组胺浓度和临床症状。使用学生t检验、发病率的卡方检验以及连续数据的曼-惠特尼U检验进行统计分析。
安慰剂组组胺释放的发生率为55.5%(5/9),而抗组胺药组为37.5%(3/8)(p > 0.05,卡方检验)。在肠系膜牵拉后5分钟和20分钟时,安慰剂组的血浆组胺水平(均值±标准差)高于抗组胺药组,但差异未达到统计学意义。安慰剂组心律失常的发生率(6次)显著高于抗组胺药组(无)(p = 0.005,卡方检验)。两组间收缩压无统计学差异(例如,肠系膜牵拉后5分钟,均值±标准差;安慰剂组111±20 mmHg,抗组胺药组119±35 mmHg)。然而,在安慰剂组中,只有在反复降低麻醉气体浓度并增加血管升压药/液体输注量后,血流动力学才在肠系膜牵拉后5分钟稳定下来(安慰剂组 = 20次/抗组胺药组 = 8次,p = 0.001,t检验)。
预防性给予抗组胺药可降低组胺释放的发生率、心律失常的发生率以及肠系膜牵拉期间稳定措施的使用量。H1和H2抗组胺药的预防性用药可能在围手术期有益,因此在AAA手术中应予以考虑。